Pancreatic Cancer Trial, Recruiting NCT04239573 Sponsor: ECOG-ACRIN Cancer Research Group Condition: Pancreatic Cancer
Back to Pancreatic Cancer

Pancreatic Cancer Trial, Recruiting

NCT04239573
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are aged between 50 and 75 years old.
  • People who have had a CT scan, MRI, or endoscopic ultrasound (a camera procedure to look inside the body) within the past 6 months that found one or more fluid-filled sacs (cysts) on the pancreas, each measuring at least 1 cm.

Who may not be able to join:

  • People who currently have, or have had in the past, a pancreatic condition involving inflammation (either sudden or long-term pancreatitis).
  • People who are known to be pregnant.
  • People who have previously been diagnosed with any form of pancreatic cancer.
  • People who have previously had surgery to remove part of the pancreas.
  • People whose pancreatic cysts are of a type considered to carry no risk of becoming cancerous, such as a pseudocyst or a classic serous cystic lesion.
  • People who have a parent, full sibling, or child (biological) who has been diagnosed with pancreatic cancer.
  • People whose cysts show features that would normally lead doctors to consider surgery straight away, such as growths within the cyst wall, a solid area inside the cyst, a widened pancreatic duct (10mm or more), or yellowing of the skin caused by the cyst blocking bile flow (confirm with trial site).
  • People who have another serious health condition that would make the endoscopic ultrasound procedure or pancreatic surgery unsafe for them.
  • People who have already been taking part in an organised, regular monitoring programme specifically watching their pancreatic cyst for more than 1 year.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
ECOG-ACRIN Cancer Research Group
Registry
ClinicalTrials.gov
Start date
16 June 2020
Est. completion
31 December 2030

Where this trial is recruiting

🇨🇦 Canada Puerto Rico 🇰🇷 South Korea 🇺🇸 United States

Primary endpoints

Time-to-finding of a worrisome feature and/or high-risk stigmata on computed tomography (CT) or magnetic resonance imaging (MRI); Occurrence of an "unfavorable" outcome (PRIOR TO ADDENDUM #5 08/13/2024)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov